Blood flow, flow reserve, and glucose utilization in viable and nonviable myocardium in patients with ischemic cardiomyopathy

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 40, Issue 4, 2013, Pages 532-541

  Zhang, Xiaoli ^a,b   Schindler, Thomas H ^c   Prior, John O ^d   Sayre, James ^e   Dahlbom, Magnus ^a   Huang, Sung Cheng ^a   Schelbert, Heinrich R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FUWAI HOSPITAL   (China)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glucose metabolism; Ischemic cardiomyopathy; Myocardial flow reserve; Myocardial viability

Indexed keywords

AMMONIA N 13; DIPYRIDAMOLE; FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRACTIONAL FLOW RESERVE; GLUCOSE UTILIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HUMAN; ISCHEMIC CARDIOMYOPATHY; MALE; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY;

ADULT; AGED; BLOOD GLUCOSE; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NITROGEN RADIOISOTOPES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REGIONAL BLOOD FLOW;

EID: 84875701597     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2311-9     Document Type: Article

References (27)

1. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
2. Beanlands RS, Hendry PJ, Masters RG, deKemp RA, Woodend K, Ruddy TD. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 1998;98(19 Suppl):II51-6.
3. Elsässer A, Schlepper M, Klövekorn WP, Cai WJ, Zimmermann R, Müller KD, et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation 1997;96:2920-31.
4. Fallavollita JA, Canty Jr JM. Differential 18F-2-deoxyglucose uptake in viable dysfunctional myocardium with normal resting perfusion: evidence for chronic stunning in pigs. Circulation 1999;99:2798-805.
5. Canty Jr JM, Fallavollita JA. Hibernating myocardium. J Nucl Cardiol 2005;12:104-19.
6. Prior JO, Schindler TH, Facta AD, Hernandez-Pampaloni M, Campisi R, Dahlbom M, et al. Determinants of myocardial blood flow response to cold pressor testing and pharmacologic vasodilation in healthy humans. Eur J Nucl Med Mol Imaging 2007;34:20-7.
7. Schindler TH, Zhang XL, Prior JO, Cadenas J, Dahlbom M, Sayre J, et al. Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with (13)N-ammonia and PET. Eur J Nucl Med Mol Imaging 2007;34:1178-88.
8. Campisi R, Czernin J, Schöder H, Sayre JW, Marengo FD, Phelps ME, et al. Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity. Circulation 1998;98:119-25.
9. Machac J, Bacharach SL, Bateman TM, Bax JJ, Beanlands R, Bengel F, et al. Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol 2006;13:e121-51.
10. Schöder H, Campisi R, Ohtake T, Hoh CK, Moon DH, Czernin J, et al. Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction. J Am Coll Cardiol 1999;33:1328-37.
11. Nekolla SG, Miethaner C, Nguyen N, Ziegler SI, Schwaiger M. Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography. Eur J Nucl Med 1998;25:1313-21.
12. Porenta G, Kuhle W, Czernin J, Ratib O, Brunken RC, Phelps ME, et al. Semiquantitative assessment of myocardial blood flow and viability using polar map displays of cardiac PET images. J Nucl Med 1992;33:1628-36.
13. Canty Jr JM, Suzuki G. Myocardial perfusion and contraction in acute ischemia and chronic ischemic heart disease. J Mol Cell Cardiol 2012;52:822-31.
14. Canty Jr JM, Fallavollita JA. Hibernating myocardium represents a primary downregulation of regional myocardial oxygen consumption distal to a critical coronary stenosis. Basic Res Cardiol 1995;90:5-8.
15. vom Dahl J, Eitzman DT, al-Aouar ZR, Kanter HL, Hicks RJ, Deeb GM, et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994;90:2356-66.
16. Tio RA, Dabeshlim A, Siebelink HM, de Sutter J, Hillege HL, Zeebregts CJ, et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 2009;50:214-9.
17. Depré C, Vanoverschelde JL, Melin JA, Borgers M, Bol A, Ausma J, et al. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol 1995;268(3 Pt 2):H1265-75.
18. Klein C, Nekolla SG, Bengel FM, Momose M, Sammer A, Haas F, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162-7.
19. Depré C, Vanoverschelde JL, Gerber B, Borgers M, Melin JA, Dion R. Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischemic dysfunction undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 1997;113:371-8.
20. Gerber BL, Melin JA, Bol A, Labar D, Cogneau M, Michel C, et al. Nitrogen-13-ammonia and oxygen-15-water estimates of absolute myocardial perfusion in left ventricular ischemic dysfunction. J Nucl Med 1998;39:1655-62.
21. Fallavollita JA, Trojan C, Canty Jr JM. Transmural distribution of FDG uptake in stunned myocardium. Am J Physiol Heart Circ Physiol 2000;279:H102-9.
22. Brosius 3rd FC, Liu Y, Nguyen N, Sun D, Bartlett J, Schwaiger M. Persistent myocardial ischemia increases GLUT1 glucose transporter expression in both ischemic and non-ischemic heart regions. J Mol Cell Cardiol 1997;29:1675-85.
23. Depre C, Kim SJ, John AS, Huang Y, Rimoldi OE, Pepper JR, et al. Program of cell survival underlying human and experimental hibernating myocardium. Circ Res 2004;95:433-40.
24. Fallavollita JA, Perry BJ, Canty Jr JM. 18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium. Circulation 1997;95:1900-9.
25. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-35.
26. Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002;105:186-93.
27. Maron MS, Olivotto I, Maron BJ, Prasad SK, Cecchi F, Udelson JE, et al. The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 2009;54:866-75.